FREESTYLE LIBRE 2
Report
- Report Number
- 2954323-2021-96252
- Event Type
- Injury
- Date Received
- December 21, 2021
- Date of Event
- December 16, 2021
- Report Date
- December 28, 2021
- Manufacturer
- ABBOTT DIABETES CARE INC
- Product Code
- QLG
- PMA / PMN Number
- K193371
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- GM
- Reporter Occupation
- 003
Narratives
THE PRODUCT HAS BEEN REQUESTED BACK FOR AN INVESTIGATION. A FOLLOW-UP REPORT WILL BE SUBMITTED ONCE ADDITIONAL INFORMATION IS OBTAINED. THE DEVICE MANUFACTURING DATE IS UNKNOWN. THE DATE ENTERED IS THE DATE ABBOTT DIABETES CARE BECAME AWARE OF THE EVENT. ALL PERTINENT INFORMATION AVAILABLE TO ABBOTT DIABETES CARE HAS BEEN SUBMITTED.
REPEATED ATTEMPTS BY ADC TO RETRIEVE THE PRODUCT WERE UNSUCCESSFUL AND/OR THE CUSTOMER DISCARDED THE PRODUCT. NO PRODUCT HAS BEEN RETURNED. AN EXTENDED INVESTIGATION HAS BEEN PERFORMED FOR THE REPORTED COMPLAINT AND IT HAS BEEN DETERMINED THAT THERE WAS NO INDICATION THAT THE PRODUCT DID NOT MEET SPECIFICATION. THE DHRS (DEVICE HISTORY REVIEW) FOR THE LIBRE SENSOR AND LIBRE SENSOR KITS WERE REVIEWED AND THE DHRS SHOWED THE LIBRE SENSOR AND LIBRE SENSOR KITS PASSED ALL TESTS PRIOR TO RELEASE. IF THE PRODUCT IS RETURNED, A PHYSICAL INVESTIGATION WILL BE PERFORMED AND A FOLLOW-UP REPORT SUBMITTED. ALL PERTINENT INFORMATION AVAILABLE TO ABBOTT DIABETES CARE HAS BEEN SUBMITTED.
A CUSTOMER REPORTED AN ERROR CODE WITH THE FREESTYLE LIBRE 2 SENSOR, AND WAS THEREFORE UNABLE TO OBTAIN SCAN READINGS. THE CUSTOMER SUBSEQUENTLY EXPERIENCED A SEIZURE AND WAS TAKEN TO A HEALTH CLINIC WHERE SHE RECEIVED TREATMENT OF GLUCOSE INJECTION FROM A HEALTHCARE PROFESSIONAL. THE CUSTOMER WAS ADDITIONALLY GIVEN 400 MG ANTICONVULSANT, VITAMINS, "CALCIUM QUETERAPEN 100", SLEEP TABLET, AND "STOMACH TABLET" MEDICATIONS. THERE WAS NO REPORT OF DEATH OR PERMANENT INJURY ASSOCIATED WITH THIS EVENT.
A CUSTOMER REPORTED AN ERROR CODE WITH THE FREESTYLE LIBRE 2 SENSOR, AND WAS THEREFORE UNABLE TO OBTAIN SCAN READINGS. THE CUSTOMER SUBSEQUENTLY EXPERIENCED A SEIZURE AND WAS TAKEN TO A HEALTH CLINIC WHERE SHE RECEIVED TREATMENT OF GLUCOSE INJECTION FROM A HEALTHCARE PROFESSIONAL. THE CUSTOMER WAS ADDITIONALLY GIVEN 400 MG ANTICONVULSANT, VITAMINS, "CALCIUM QUETERAPEN 100", SLEEP TABLET, AND "STOMACH TABLET" MEDICATIONS. THERE WAS NO REPORT OF DEATH OR PERMANENT INJURY ASSOCIATED WITH THIS EVENT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1949809 | FREESTYLE LIBRE 2 | FLASH GLUCOSE MONITORING SYSTEM | QLG | ABBOTT DIABETES CARE INC | 71992-01 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Unknown | Required Intervention |